Nonnarcotic analgesic use and the risk of hypertension in US women

Hypertension

Volumn 40, Issue 5, 2002, Pages 604-608

  Dedier, Julien ^a   Stampfer, Meir J ^a   Hankinson, Susan E ^a   Willett, Walter C ^a   Speizer, Frank E ^a   Curhan, Gary C ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

Blood pressure; Drug therapy; Hypertension, essential; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; COUNSELING; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PAIN; PREVALENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RISK ASSESSMENT; SEX DIFFERENCE;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOOD PRESSURE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NURSES; ODDS RATIO; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; RISK FACTORS; UNITED STATES;

EID: 0036840954     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000035856.77718.DA     Document Type: Article

References (26)

1. Kaufman DW, Kelly JP, Anderson TE, Rosenberg L, Mitchell AA. A comprehensive population-based survey of medication use in the United States: The adult population. Pharmacoepidemiol Drug Saf. 2000;9:S60.
2. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153:477-484.
3. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994;121:289-300.
4. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994;272:781-786.
5. Zenser TV, Mattammal MB, Herman CA, Joshi S, Davis BB. Effect of acetaminophen on prostaglandin E2 and prostaglandin F2alpha synthesis in the renal inner medulla of rat. Biochim Biophys Acta. 1978;542:486-495.
6. Mattammal MB, Zenser TV, Brown WW, Herman CA, Davis BB. Mechanism of inhibition of renal prostaglandin production by acetaminophen. J Pharmacol Exp Ther. 1979;210:405-409.
7. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975;72:3073-3076.
8. Walter E, Kaufmann W, Oster P. Does chronic aspirin treatment increase blood pressure in man? Klin Wochenschr. 1981;59:297-299.
9. Chalmers JP, West MJ, Wing LM, Bune AJ, Graham JR. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens [A]. 1984;6:1077-1093.
10. Curhan G, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med. 2002. In press.
11. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
12. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, I: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
13. Colditz GA. The nurses' health study: A cohort of US women followed since 1976. J Am Med Womens Assoc. 1995;50:40-44.
14. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
15. Cinotti GA, Pugliese F. Prostaglandins in blood pressure regulation. Kidney Int Suppl. 1988;25:S57-S60.
16. Pancera P, Arosio E, Minuz P, Pirante F, Ribul M, Lechi A. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. Prostaglandins Leukot Essent Fatty Acids. 1996;54:217-222.
17. Nowak J, Wennmalm A. Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man. Acta Physiol Scand. 1978;102:484-491.
18. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994;271:927-934.
19. Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C. Effects of sulindac and ibuprofen in patients with chronic glomerular disease: Evidence for the dependence of renal function on prostacyclin. N Engl J Med. 1984;310:279-283.
20. Kauker ML. Prostaglandin E2 effect from the luminal side on renal tubular 22Na efflux: Tracer microinjection studies. Proc Soc Exp Biol Med. 1977;154:274-277.
21. Stokes JB, Kokko JP. Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule. J Clin Invest. 1977;59:1099-1104.
22. Needleman P, Douglas JR Jr, Jakschik B, Stoecklein PB, Johnson EM Jr. Release of renal prostaglandin by catecholamines: Relationship to renal endocrine function. J Pharmacol Exp Ther. 1974;188:453-460.
23. Johnson AG, Nguyen TV, Owe-Young R. Williamson DJ, Day RO. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: The role of endothelin-1. J Hum Hypertens. 1996;10:257-261.
24. Chrischilles EA, Wallace RB. Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population. J Gerontol. 1993;48:M91-M96.
25. Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J. Non-steroidal anti-inflammatory drugs and hypertension in the elderly: A community-based cross-sectional study. Br J Clin Pharmacol. 1993;35:455-459.
26. Dubach UC, Rosner B, Sturmer T. An epidemiologic study of abuse of analgesic drugs: Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987). N Engl J Med. 1991;324:155-160.